Concepedia

Andrew D. Weinberg

AD

94

Publications

10.6K

Citations

51

H-Index

1983

Active since

Affiliations

Providence Portland Medical Center(Current)

Oregon Health & Science University

Cancer Research Center

Portland VA Medical Center

Institute of Neuroimmunology of the Slovak Academy of Sciences

Andrew D. Weinberg is an author at Providence Portland Medical Center specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1983–2023

94

Publications

94

IL-4 directs the development of Th2-like helper effectors.

Susan L. Swain, Andrew D. Weinberg, M English et al. · The Journal of Immunology · 1990 · 1.3K citations · Full text

, , +17

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

Thomas Duhen, Rebekka Duhen, Ryan Montler et al. · Nature Communications · 2018 · 903 citations · Full text

Ox-40 Ligand: A Potent Costimulatory Molecule for Sustaining Primary CD4 T Cell Responses

Irene Gramaglia, Andrew D. Weinberg, Michael Lemon et al. · The Journal of Immunology · 1998 · 519 citations · Full text

, , +17

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas P. Morris et al. · Cancer Research · 2013 · 502 citations · Full text

Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR

Barbara Valzasina, Cristiana Guiducci, Heidrun Dislich et al. · Blood · 2005 · 430 citations · Full text

Rows per page

1–5 of 94